Skip to main content
Menu
US

Angiotensin II (human), [125I]-Tyr4, 10 μCi

Angiotensin II (human), labeled with 125I on the tyrosine (Tyr4) residue. Angiotensin II binds and activates angiotensin II receptor type 1 (AT1) and type 2 (AT2) receptors, a class of GPCRs important in vasoconstriction. Angiotensin II is a potential drug target for blood pressure regulation.

For research use only. Not for use in diagnostic procedures.

Feature Specification
Fresh Lot Days Second Monday of each month
Label Position Nominally Labeled
Molecular Weight 1171
Receptor Angiotensin

Angiotensin II (human), labeled with 125I on the tyrosine (Tyr4) residue. Angiotensin II binds and activates angiotensin II receptor type 1 (AT1) and type 2 (AT2) receptors, a class of GPCRs important in vasoconstriction. Angiotensin II is a potential drug target for blood pressure regulation.

For research use only. Not for use in diagnostic procedures.

Product Variants
Unit Size: 10 µCi
Part #:
NEX105010UC
List Price
USD 1,659.00
Unit Size: 50 µCi
Part #:
NEX105050UC
List Price
USD 5,825.00

Overview

10 µCi quantities of Angiotensin II (human), [125I]-Tyr4, are available for your research.

We offer radioligands and radiolabeled biomolecules to use as tracers, for radioimmunoassays (RIAs), for autoradiographic visualization, or for performing saturation and competition radioligand binding assays to determine receptor expression levels (Bmax), dissociation constants (Kd), association and dissociation rates (kon and koff), and inhibitor constants (Ki) for a variety of receptors. We develop our radioligands to the highest specific activity possible and provide high purity resulting in low non-specific binding products. Each of our ultra-pure radiolabeled compounds is fully characterized for pharmacological action and validated in binding assays.

Radiochemicals remain the most sensitive method for probing binding biology; yielding unprecedented sensitivity gives results that technicians and scientists can trust. For over 50 years, Revvity has been a leading supplier of New England Nuclear (NEN) radiochemicals, liquid scintillation cocktails, vials and nuclear counting detection instruments.

References for NEX105:

  1. Oppermann, M., Gess, B., Schweda, F., and Castrop, H. (2009), Atrap Deficiency Increases Arterial Blood Pressure and Plasma Volume. JASN, 21 (3): 468-477.

Specifications

Molecular Weight
1171
Specific Activity
2200.0 Ci/mmol
Application
Drug Discovery & Development
Brand
NEN Radiochemicals
Buffer/Solvent
Lyophilized
Detection Modality
Radiometric
Fresh Lot Days
Second Monday of each month
Label Position
Nominally Labeled
Packaging
NENSure vial
Radioisotope
125I
Receptor
Angiotensin
Shipping Conditions
Shipped Ambient
Special Ordering Information
This is a radioactive product - shipping address must have a license to receive radioactive materials.
Storage Conditions
4°C
Therapeutic Area
Angiogenesis
Cardiovascular
Unit Size
10 µCi

Resources

Are you looking for resources, click on the resource type to explore further.

1-1 of 1 Resources
Product Info Icon
Product Info
2024 Fresh Lot Calendar

SDS, COAs, Manuals and more

Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.

Technical data sheet
+ Show more
Scroll Icon